The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
NCT Number: NCT05264298
The purpose of this study is to examine the impact of a multidisciplinary telehealth-based model of outpatient stroke care on blood pressure control following stroke, and further, to evaluate its impact on racial disparities in post-stroke blood pressure control.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Blood pressure is poorly controlled for many stroke survivors and racial disparities in blood pressure control and stroke recurrence exist.
The purpose of this study is to examine the impact of a multidisciplinary, telehealth based, outpatient model of care on outcomes after stroke with a focus on blood pressure control. The Video-based Intervention to Reduce Treatment and Outcome Disparities in Adults Livings with Stroke and Transient Ischemic Attack (VIRTUAL) has several components including early follow-up via telehealth with a multidisciplinary team, remote blood pressure monitoring, and medication adjustment by a pharmacist.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
At the time of discharge, stroke survivors in the VIRTUAL arm will receive a package containing an iPad and a remote BP monitoring device that allows transmission of BP to the study team.The first telehealth visit will occur 7-14 days after discharge. Patient will be counseled on the importance of BP monitoring, salt reduction, and the importance of diet and exercise for stroke prevention. Medications, side effects and interactions will be reviewed. The social worker will refer the patient to specific resources according to social needs abd patient will be referred to a primary care provider if they do not have one. Subsequent video visits will be 1-month (30 days +/- 7) , 3 months (90 days +/- 14), and 5 months (150 days +/- 14) days after enrollment.
Participants randomized to standard care will receive an educational packet and a blood pressure monitor prior to hospital discharge. They will be contacted by a social worker to determine if they received their medications and appointments. The stroke practitioner will evaluate the patients at 7-14 days and then follow up according to current standard of care. They will be seen over video or in-person, according to their preference and capabilities. The pharmacist will contact patients at 1-month (30 +/- 7 days) days over the telephone to review BP logs and will make recommendations to their primary care provider to adjust BP medications. Subsequent pharmacist calls will occur monthly until 6 months and recommendations for medication adjustments will be communicated to their primary care provider.
Time frame: 6 months after discharge
Proportion of participants with controlled BP according to 24- hour ambulatory BP (<125/75 mmHg)
Time frame: 12 months after discharge
Proportion of participants with controlled BP according to 24- hour ambulatory BP (<125/75 mmHg)
Time frame: 12 months after discharge
Number of patients with myocardial infarction, ischemic or hemorrhagic stroke, coronary revascularization, acute cardiac death, and heart failure hospitalization)
Time frame: 3 months after hospital discharge
Proportion of uninsured patients who obtain insurance
Time frame: 6 months after hospital discharge
Proportion of uninsured patients who obtain insurance
Time frame: 3 months after hospital discharge
Number of hospital readmissions, emergency department (ED) visits, and urgent care visits
Time frame: 6 months after hospital discharge
Number of hospital readmissions, ED visits, and urgent care visits
Time frame: 12 months after hospital discharge
Number of hospital readmissions, ED visits, and urgent care visits
Time frame: 6 month
24 hour systolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 12 month
24 hour systolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 6 month
24 hour diastolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 12 month
24 hour diastolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 6 month
Daytime systolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 12 month
Daytime systolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 6 month
Daytime diastolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 12 month
Daytime diastolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 6 month
Night time systolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 12 month
Night time systolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 6 month
Night time diastolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 12 month
Night time diastolic blood pressure as assessed by an ambulatory blood pressure monitor
Time frame: 6 months
Among participants who are tobacco users at time of enrollment
Time frame: 12 months
Among participants who are tobacco users at time of enrollment
Time frame: 6 months
Among participants who are tobacco users at time of enrollment
Time frame: 12 months
Among participants who are tobacco users at time of enrollment
Time frame: 6 months
Patient Health Questionnaire 9 total score ranges from 0 to 27
Time frame: 12 months
Patient Health Questionnaire 9 total score ranges from 0 to 27
The University of Texas Health Science Center, Houston
Other
Video-based Intervention to Reduce Treatment and OUtcome Disparities in Adults Living With Stroke or Transient Ischemic Attack (VIRTUAL)
Acronym: VIRTUAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739134
ALS, Brain Damage, Chronic
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT05047172
Arterial Occlusive Diseases, Arteriosclerosis
Birmingham, Alabama, United States
View Trial DetailsNCT07710937
Brain Diseases, Cardiovascular Diseases
Multan Khurd, Pakistan
View Trial DetailsNCT07666906
Brain Diseases, Cardiovascular Diseases
Faisalābad, Punjab Province, Pakistan
View Trial Details